Financials
- Market Capitalization 10.8 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-45.32
市销率
13.63
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 842 | IBRX ImmunityBio, Inc. - Common Stock | 10.15 USD | -3.43% | -1.65% | +28.64% | +326.47% | 10.76 B USD | ||
| 850 | PCVX Vaxcyte, Inc. - Common Stock | 69.06 USD | -3.25% | -5.10% | +15.02% | +63.26% | 10.28 B USD | ||
| 856 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 55.89 USD | +1.99% | -3.32% | -15.95% | +6.76% | 10.82 B USD | ||
| 891 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.60 USD | -0.23% | +4.27% | +2.20% | +100.78% | 10.13 B USD |